Quarterly report [Sections 13 or 15(d)]

Other current assets (Tables)

v3.25.2
Other current assets (Tables)
6 Months Ended
Jun. 30, 2025
Other current assets  
Summary of other current assets

Other current assets consisted of the following (in thousands):

​

​

​

​

​

​

​

​

​

June 30, 

​

December 31, 

​

    

2025

​

2024

Research and development credits receivable

 

$

18,277

​

$

12,929

Prepayments

 

​

8,232

​

​

10,033

Clinical materials

 

​

—

​

​

59

VAT receivable

​

​

1,305

​

​

1,599

Other current assets

 

​

3,516

​

​

3,170

​

​

$

31,330

​

$

27,790